Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IMCR
IMCR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMCR News
uniQure Achieves Major Regulatory Milestone for Gene Therapy
1d ago
NASDAQ.COM
Beam Therapeutics Receives FDA Clearance for Gene-Editing Therapy
2d ago
NASDAQ.COM
Mirum and Incyte Report Positive Results for FOP Study
4d ago
NASDAQ.COM
Immunocore Reports Positive Phase 1/2 Data for Brenetafusp in Melanoma Treatment
Jun 01 2026
NASDAQ.COM
Immunocore Updates Phase 1 Data on Brenetafusp for Advanced Melanoma
May 31 2026
Newsfilter
Immunocore Updates Phase 1 Data on Brenetafusp for Advanced Melanoma
May 31 2026
Yahoo Finance
Black Diamond Therapeutics Shares Plunge 35.8% Amid Mixed Phase II Results
May 25 2026
NASDAQ.COM
Immunocore Q1 Earnings Beat Expectations
May 07 2026
seekingalpha
Immunocore Holdings Shares Show Oversold Signal
Apr 27 2026
NASDAQ.COM
KIMMTRAK Doubles Five-Year Survival Rate for Metastatic Uveal Melanoma Patients
Apr 19 2026
Newsfilter
KIMMTRAK Doubles Five-Year Survival Rate for Metastatic Uveal Melanoma Patients
Apr 19 2026
Yahoo Finance
Immunocore (IMCR) Q4 2025 Earnings Call Transcript
Feb 25 2026
NASDAQ.COM
Immunocore Q4 Earnings Report Analysis
Feb 25 2026
seekingalpha
Immunocore Set to Announce Q4 Earnings on February 25
Feb 24 2026
seekingalpha
Immunocore Announces R&D Leadership Changes
Jan 30 2026
Newsfilter
Immunocore to Showcase at Upcoming Investor Events
Nov 10 2025
Newsfilter
Show More News
